Beta‐blockers reduce the release and synthesis of endothelin‐1 in human endothelial cells

Abstract

The effect of beta-adrenergic antagonists on ET-1 production of the endothelium may at least partially explain the efficacy of beta-blockers in the treatment of diseases such as advanced heart failure, essential hypertension as well as acute coronary syndromes.